ITR Laboratories will be attending BioFuture in New York this October.

Bassem Attalla will be representing ITR on-site from October 27–28 and meeting with innovators, biotech companies, and development partners focused on advancing next-generation therapeutics.

From early preclinical strategy through IND-enabling studies, ITR provides integrated toxicology, analytical, and bioanalytical services designed to help support efficient drug development programs.

If you’ll be attending BioFuture, we’d be happy to connect and discuss your upcoming projects.